Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Nigel Rawson
Portable, accessible, universal health care in Canada: fact or myth?
Portable, accessible, universal health care in Canada: fact or myth? Author(s) Source National Newswatch Posted Share Canada’s publicly-funded health care insurance is governed by the 1984 federal Canada Health Act (CHA) that has five key principles: public administration, universality, comprehensiveness, portability, and accessibility.
Opinion: Trump wants higher drug prices in Canada. That might not be bad Original
Our insistence on low prices for patented drugs may result in both less and slower access to life-saving new medicines for Canadians U.S. President Donald Trump listens during an event about prescription drug prices in the South Court Auditorium in the Eisenhower Executive Office Building on the White House campus, Monday, May 18, 2026, in Washington. Last year, Donald Trump introduced “most-favoured-nation” (MFN) drug pricing for the United States.
Trump’s Most Favoured Nation drug pricing risks further delays in…
Topics Trump’s Most Favoured Nation drug pricing risks further delays in Canada for pharmaceuticals Author(s) Source Macdonald-Laurier Institute Posted Share If Canada doesn’t take actions like the United Kingdom to attain Most Favoured Nation status, delays will likely be even longer as companies deprioritize launching new drugs here. United States President Donald Trump’s focus on trade and tariff deals extends to pharmaceuticals.
Appropriate medication use includes access to state-of-the-art drugs
Topics Appropriate medication use includes access to state-of-the-art drugs Author(s) Source Macdonald-Laurier Institute Posted Share Once again, Canada’s many layers of bureaucratic gatekeeping are blocking Canadian patients from accessing an innovative new drug.
Rare disease sufferers in Canada: orphans of ‘universal’ Medicare
Topics Rare disease sufferers in Canada: orphans of ‘universal’ Medicare Author(s) Source Macdonald-Laurier Institute Posted Share About 11,000 rare diseases have been identified. Individually, each disease affects from fewer than 100 to a few thousand Canadians. In total, these diseases afflict up to three million. The exact cause of many is unknown. But it’s clear that inadequate access to treatment in Canada is driven by government policy.
Consequences of Canada’s Drug Agency reimbursement recommendations f
Introduction Canada is not a unitary country but a federation of 10 provinces and three territories.
Opinion: Some drugs with sky-high prices may save on health-care costs Original
Skip to Content Advertisement 1 Decisions on whether to fund very expensive treatments should take into account all of the effects on the health-care system Article content This summer British Columbians debated whether their provincial government should continue to pay for an expensive medicine for 10-year-old Charleigh Pollock, who has a rare disorder called Batten disease.
Opinion: Ottawa is underfunding pharmacare and dental care, exacerbating current inequities
As presently implemented, these programs satisfy few Canadians’ expectations or needs Published Jul 16, 2025 • Last updated 11 hours ago • 3 minute read Photo by Pierre Drap via istock.xchng Article content The Trudeau government introduced the Canadian Dental Care Plan (CDCP) for Canadians without dental insurance and the framework for a national pharmacare plan to help Canadians pay for prescription medicine.
Opinion: Ottawa is underfunding pharmacare and dental care, exacerbating current inequities Original
Skip to Content Advertisement 1 As presently implemented, these programs satisfy few Canadians’ expectations or needs Article content The Trudeau government introduced the Canadian Dental Care Plan (CDCP) for Canadians without dental insurance and the framework for a national pharmacare plan to help Canadians pay for prescription medicine. Prime Minister Mark Carney has stated that his government will retain both programs, but are they what Canadians want or need?
Opinion: Ottawa is underfunding pharmacare and dental care, exacerbating current inequities
The Trudeau government introduced the Canadian Dental Care Plan (CDCP) for Canadians without dental insurance and the framework for a national pharmacare plan to help Canadians pay for prescription medicine. Prime Minister Mark Carney has stated that his government will retain both programs, but are they what Canadians want or need? Dental associations have expressed concern about the CDCP’s administrative burden and sustainability.
Opinion: One federal agency we could axe? The drug prices review board Original
The Patented Medicine Prices Review Board (PMPRB), Canada’s federal gatekeeper under the Patent Act, sets maximum prices for new patented medicines. Until recently, it did this by comparing a drug’s list price in Canada with that in seven other countries. In 2017, then-federal health minister Jane Philpott chose to try to use the Review Board to drastically reduce Canadian drug prices.
Opinion: One federal agency we could axe? The drug prices review board
Financial Personal Opinion: One federal agency we could axe? The drug prices review board The Patented Medicine Prices Review Board doesn't affect drug prices in most provinces but costs $18 million a year. Do we still need it?
No Rare Disorder Sufferer Should be Left Behind: Troubling Case of…
For most people diagnosed with a rare disorder, the situation is dire. Treatments exist for only one in 20 of the thousands of different rare disorders, beside symptom relief and palliative care. Although each disorder impacts a small number of individuals, at least million Canadians have a rare disease. Many can cause great suffering, physical and/or mental disability, and premature death.
Opinion: Ottawa’s pharmacare plan looks grim for diabetics Original
We apologize, but this video has failed to load. tap here to see other videos from our team. Try refreshing your browser, or Opinion polls regularly show that most Canadians support the idea of national pharmacare. But they’re likely envisioning a comprehensive system covering a broad range of innovative medicines — not unlike what many of them have in their private plans.
Opinion: Hassling drug companies won't aid 'health emergency readiness' Original
We apologize, but this video has failed to load. tap here to see other videos from our team. Try refreshing your browser, or The federal government is creating yet another new agency, Health Emergency Readiness Canada (HERC), which will be “dedicated to protecting Canadians against future pandemics and delivering on Canada’s life sciences and medical countermeasures readiness objectives.” It’s only three years behind the European Union’s readiness initiative.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nigel
Contact Nigel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack